|
Groups
| | |
A
|
B
|
C
|
D
|
E
|
F
|
|---|
|
Virus tested
| | |
PRVΔTK&gE-AH02
|
Bartha K61
|
/
|
/
|
|
Dosage (TCID50)
| | |
103
|
104
|
105
|
105
|
/
|
/
|
|
Inoculation route
| | |
Intramuscularly
|
|
ELISA antibodies against PRV gB or gE
|
B.V.
|
gB+
|
0a/4b
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
|
gE+
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
|
7d P.V.
|
gB+
|
4/4
|
4/4
|
4/4
|
4/4
|
0/4
|
0/4
|
|
gE+
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
|
14 d P.C.
|
gB+
|
4/4
|
4/4
|
4/4
|
4/4
|
0/4
|
0/4
|
|
gE+
|
4/4
|
4/4
|
4/4
|
4/4
|
1/1
|
0/4
|
|
Clinical signs P.V.
| |
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
|
Fever frequency (≥40.5 °C) P.V.
| |
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
0/4
|
|
Virus shedding P.V.
| |
0/4
|
0/4
|
0/4
|
0/4
|
/
|
/
|
|
Fever frequency (≥40.5 °C) P.C.
| |
0/4
|
0/4
|
0/4
|
4/4
|
4/4
|
0/4
|
|
Clinical signs P.C.
|
Morbidity
|
0/4
|
0/4
|
0/4
|
0/4
|
4/4
|
0/4
|
|
Duration (days)
|
/
|
/
|
/
|
/
|
4~ 9
|
/
|
|
Mortality
|
0/4
|
0/4
|
0/4
|
0/4
|
3/4
|
0/4
|
|
Virus shedding P.C.
|
Frequency
|
0/4
|
0/4
|
0/4
|
4/4
|
4/4
|
0/4
|
|
Duration (days)
|
/
|
/
|
/
|
3~ 5
|
2~ 9
|
/
|
|
Lung lesions
| |
0/4
|
0/4
|
0/4
|
2/4
|
4/4
|
0/4
|
- B.V. means before vaccination, P.V. means post vaccination, P.C. means post challenge, gB+ means antibodies against PRV gB positive, gE+ means antibodies against PRV gE positive, “a” indicates the number of piglets positive; “b” indicates the number of piglets in the group
